Alexandra Livanos, MD PhD retweetledi
Alexandra Livanos, MD PhD
87 posts
Alexandra Livanos, MD PhD
@a_livanos
Physician-scientist in gastroenterology specializing in IBD @MountSinaiGI (via @ColumbiaMed, @nyugrossman, @DukeU) | Interested in mucosal immunology
New York Katılım Ağustos 2010
563 Takip Edilen524 Takipçiler
Alexandra Livanos, MD PhD retweetledi
Every year, Jean-Frederic Colombel, MD, hosts the #GI Division #IBD Retreat to tackle the most challenging topics in #IBD. We're excited to continue this tradition at the #IBDRetreat2024! 🌟
Register now and check out the agenda: bit.ly/45lzibo
@JeanFredericCo1
English
Alexandra Livanos, MD PhD retweetledi
Online—Prediction of progression to type 1 #diabetes with dynamic #biomarkers and #risk scores thelancet.com/journals/landi… #T1D
English
Alexandra Livanos, MD PhD retweetledi
Excited to share our new work in @SciImmunology! We describe targeting of gut-associated lymphoid tissue (GALT) as a novel mode of action of anti-α4β7 therapy in IBD. Co-led by @mat_uzz & A. Seki @MehandruLab @SinaiImmunol @MountSinaiGI @IcahnMountSinai🧵
science.org/doi/10.1126/sc…
English
Alexandra Livanos, MD PhD retweetledi
Our lab is well-represented again at #ECCO2024! 😀 We are VERY proud of Hannah Bloemen who just provided an excellent talk in the plenary session on #avb6 antibodies in PSC-IBD! 👏🥳😊 @JeanFredericCo1 @a_livanos
English
Alexandra Livanos, MD PhD retweetledi
🚨My review of this outstanding work by @a_livanos out now in the newest #ECCO news issue:
ecco-ibd.eu/publications/e…
@ManasiAgrawalMD @JeanFredericCo1 @MehandruLab
🙏Thanks to @Y_ECCO_IBD for the opportunity! And in the same issue alongside great friend @Bealoquebea!
Beatriz Gros@Bealoquebea
Y-ECCO literature review @AshkanRA and I in the same ECCO news update.🤩 Dont miss these reviews🌟 So proud of you Ashkan and happy to see our faces in the same content 🙌 @Y_ECCO_IBD ecco-ibd.eu/publications/e…
English
Alexandra Livanos, MD PhD retweetledi
We are very excited to share our preprint out now in @biorxivpreprint lead by @divyajha_phd!! We describe how epithelium-associated myeloid cells in ulcerative colitis impact response to anti-TNF therapy @SinaiImmunol @MountSinaiGI @IcahnMountSinai
biorxiv.org/content/10.110…
English
Alexandra Livanos, MD PhD retweetledi
Are you a patient with #IBD? Will you help the awesome @JoanaTo62523004 and her team with a project exploring preferences for prevention and prediction of IBD? Please do take this survey and share with relatives! redcap.link/Prediction_Pre…
English
@PlevrisN @Bealoquebea @DDWMeeting Good question: some patients did seroconvert but more work needed to identify triggers!
English
Anti-integrin alfaVbeta6 are a novel predictive marker in UC nicely presented by @a_livanos at #DDW2023 @DDWMeeting #AGALIVE2023
English
Alexandra Livanos, MD PhD retweetledi
.@AimeeLeeLucasMD, Chair of the AGA Women’s Committee, with just a few of Mount Sinai’s most talented and prolific gastroenterologists at the AGA Women in GI Luncheon. .@AmerGastroAssn #mountsinai #wefindaway #womeninGI #ddw2023
English
Alexandra Livanos, MD PhD retweetledi
Outstanding presentation by @a_livanos and really interesting data. Exciting potential for understanding cause of UC! #DDW2023
Icahn School of Medicine at Mount Sinai@IcahnMountSinai
Dr. @a_livanos will present tomorrow at #DDW2023: Anti-integrin avβ6 Autoantibodies Are a Novel Predictive Biomarker in Ulcerative Colitis. For more information about @MountSinaiNYC speakers, visit: mshs.co/4175TOg #GITwitter @MountSinaiGI @DOMSinaiNYC @DDWMeeting
English
Alexandra Livanos, MD PhD retweetledi
Dr A Livanos: alpha v beta 6 antibodies in ulcerative colitis—new biomarker? #DDW2023 @a_livanos @JeanFredericCo1 @Realcecum @AshwinMDIBD
Čeština
@DCharabaty @NorthwesternMed @PDulaiMD @EugeneYenMD @NMH_SHanauerMD @ibdgijami @EdBarnesMD @GKochharMD @joshsteinbergMD @JosephHabibi_MD @AshkanRA @Bealoquebea @Waseem_AhmedMD Thanks for clarifying!
English
@a_livanos @NorthwesternMed @PDulaiMD @EugeneYenMD @NMH_SHanauerMD @ibdgijami @EdBarnesMD @GKochharMD @joshsteinbergMD @JosephHabibi_MD @AshkanRA @Bealoquebea @Waseem_AhmedMD Correct @a_livanos Because they are small molecules (& not biologic=protein) they have stable pharmacokinetics & are not affected by albumin/ protein clearance
English
#IBDMasterClass @NorthwesternMed
@PDulaiMD
💎Low albumin is a marker increased drug clearance
💡Think small molecule thérapies when a patient has low albumin
English
Alexandra Livanos, MD PhD retweetledi
New in @jclinicalinvest! We describe a case of selective IgA2 deficiency associated with Crohn's disease. Great work from @pabloimmune and team! @SinaiImmunol @IcahnMountSinai @MountSinaiGI jci.org/articles/view/…
Pablo Canales-Herrerias@pabloimmune
Excited to share our contribution to the IgA2 mystery! We describe a rare case of IgA2 deficiency linked to Crohn's disease. Out now in @jclinicalinvest 🔥 @MehandruLab @SinaiImmunol @IcahnMountSinai @MountSinaiGI jci.org/articles/view/…
English
Alexandra Livanos, MD PhD retweetledi
🎙️ TALK TODAY 🎙️ At #priismWIP we'll be hearing about integrin autoantibodies as predictive biomarkers of ulcerative colitis development from @a_livanos of the @MehandruLab. For more info, check out their recent paper in @AGA_Gastro here >>> gastrojournal.org/article/S0016-…
English
English
Hi Twitter! I have a PhD!
I have many, many people to thank for getting me to this point, but most especially @JudyCho7 and @Felix_Chuang240 . I am so fortunate to have your mentorship and support.
English